<DOC>
	<DOCNO>NCT02965495</DOCNO>
	<brief_summary>This multicenter , randomize , double-blinded , parallel , placebo-controlled , phase I/IIa clinical trial YYD302 treatment osteoarthritis knee .</brief_summary>
	<brief_title>Clinical Trial YYD302 Treatment Osteoarthritis Knee</brief_title>
	<detailed_description>phase I/IIa clinical trial YYD302 treatment osteoarthritis knee</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>1 . Males Females 40 year old 2 . According clinical diagnosis standard American College Rheumatology ( ACR ) , someone , diagnose single/both side osteoarthritis , correspond 3 condition following . Over 50 year age Less 30 minute morning stiffness Crepitus active motion 4 bony tenderness Bony enlargement Nopalpable warmth synvium 3 . Within 6 month screen visit , someone diagnose Kellgren &amp; Lawrence Grade I~III radioactive examination . 4 . By Weightbearing pain ( 100mmVAS ) examination , someone outcome single side osteoarthritis 40mm 5 . Patient ( Noresponder ) experience steady pain spite dosing NSAIDs painkiller past . 6 . Patient walk without helper like cane walker etc . ( If patient use helper routinely previous 6 month , evaluate patient include helper possible . In case , patient need use helper continuously end clinical trial test . ) 7 . Patient agree participate clinical trial . 1 . Someone BMI≥32kg/m² screen visit . 2 . Patient experience dose psychoactive drug , narcotic analgesic effect pain sense 3 month habitually . 3 . Patient administrate gastrointestinal drug ( example H₂blockers , misoprostol proton pump inhibitor ) regularly , ca n't stop inject clinical study period . 4 . Patient attend abnormal value screen test ( 2 time excess upper limit normal value ALT , AST , BUN , Serum Creatinine ) . 5 . Patient rheumarthritis inflammatory metabolic arthritis . 6 . Patients serious gastrointestinal , liver , renal , heart disease . 7 . When inflammatory disease occur joint area patient like septic arthritis . 8 . Patients skin ailment inject site joint region . 9 . Patients secondary osteoarthritis accord Ochronosis , Hemochromatosis systemic disease . 10 . Patients severe pain like Sudek 's atrophy , Paget 's disease , Spinal disc herniation . 11 . Polyarticular patient suffer seriously osteoarthritis part affect judge knee joint pain . 12 . Patients diagnose clear interval disappearance knee joint Xray . 13 . Patients administrate drug baseline visit . Patients injected HA target knee joint recent 9 month . Patients inject HA part knee joint recent 6 month . Patients injected steroid intraarticular knee joint . Patients administrate steroid systemically oral medication ( But , except inhalation ) 14 . Patients joint effusion trouble judge positive test like Patella tap test . 15 . Patients target knee joint gotten surgical operation history include Arthroscopy within past one year ( In case side knee joint hip joint gotten surgical operation history , except patient possibility influence target knee joint 's appraisal . 16 . Patients operation history target knee joint . 17 . Patients height weight aerobic exercise anaerobic exercise . 18 . Patients need administrate anticoagulant agent together ( But , except 300mg daily dose aspirin ) 19 . Patients hypersensitivity history Investigational Product . 20 . In midst woman childbearing year , patient disagree * contraception medically permit method 12 week administrate investigational product . * The contraception medically permit method : Condom , In case use injection insertion , In case instal intrauterine contraception device etc . 21 . Patients injected investigational product time within 30 day participate clinical trail . 22 . Besides , patient difficulty participate clinical trial continuously Principle Investigator ( PI ) 's decision .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Osteoarthritis</keyword>
</DOC>